Insights

Innovative Diagnostic Technology Remidio's advanced, AI-driven retinal imaging devices and successful regulatory approvals, including CDSCO and CE marking, position it as a leading provider of early disease detection solutions. This offers significant sales opportunities in markets seeking reliable ophthalmic diagnostic tools for conditions like diabetic retinopathy, glaucoma, and AMD.

Global Market Reach With over 16 million patients screened across 40 countries, Remidio has established a strong international presence. Opportunities exist for expanding sales into emerging markets and healthcare systems that prioritize early screening, telemedicine integration, and affordable diagnostic solutions.

Strategic Collaborations Partnerships with organizations like Seva Foundation and RetinaRisk enhance Remidio's product offerings and credibility. These collaborations can be leveraged to introduce joint solutions to new clients and healthcare providers seeking comprehensive retinal screening tools.

Expanding Product Portfolio Recent launches such as the Neubo 130 neonatal retinal imaging system demonstrate the company's innovation pipeline. Sales efforts can capitalize on these new product lines targeting specialized healthcare segments like neonatal and systemic disease detection.

Growth Potential With revenues estimated between $1M and $10M and recent leadership additions, Remidio shows signs of accelerating growth. Engaging with the company during its expansion phase presents opportunities to offer complementary solutions and integrate into its broader sales and distribution strategies.

Remidio Tech Stack

Remidio uses 8 technology products and services including Facebook Pixel, Varnish, WordPress, and more. Explore Remidio's tech stack below.

  • Facebook Pixel
    Analytics
  • Varnish
    Caching
  • WordPress
    Content Management System
  • jQuery UI
    Javascript Libraries
  • Modernizr
    Javascript Libraries
  • Google Reviews
    Online Review Management
  • Hello Bar
    Widgets
  • Facebook
    Widgets

Remidio's Email Address Formats

Remidio uses at least 1 format(s):
Remidio Email FormatsExamplePercentage
First@remidio.comJohn@remidio.com
88%
FirstMiddleLast@remidio.comJohnMichaelDoe@remidio.com
5%
FLast@remidio.comJDoe@remidio.com
5%
FirstL@remidio.comJohnD@remidio.com
2%

Frequently Asked Questions

Where is Remidio's headquarters located?

Minus sign iconPlus sign icon
Remidio's main headquarters is located at Peenya Industrial Estate 1st Main Road No, 1-51-2/12, Vacuum Techniques Compound, 1st Cross Rd Bengaluru North, Karnataka 560058 IN. The company has employees across 3 continents, including AsiaNorth AmericaEurope.

What is Remidio's official website and social media links?

Minus sign iconPlus sign icon
Remidio's official website is remidio.com and has social profiles on LinkedIn.

What is Remidio's NAICS code?

Minus sign iconPlus sign icon
Remidio's NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does Remidio have currently?

Minus sign iconPlus sign icon
As of October 2025, Remidio has approximately 207 employees across 3 continents, including AsiaNorth AmericaEurope. Key team members include Chief Executive Officer: A. S.Coo- Remidio India: W. D. S.Chief Commercial Officer Usa: E. H.. Explore Remidio's employee directory with LeadIQ.

What industry does Remidio belong to?

Minus sign iconPlus sign icon
Remidio operates in the Medical Equipment Manufacturing industry.

What technology does Remidio use?

Minus sign iconPlus sign icon
Remidio's tech stack includes Facebook PixelVarnishWordPressjQuery UIModernizrGoogle ReviewsHello BarFacebook.

What is Remidio's email format?

Minus sign iconPlus sign icon
Remidio's email format typically follows the pattern of First@remidio.com. Find more Remidio email formats with LeadIQ.

When was Remidio founded?

Minus sign iconPlus sign icon
Remidio was founded in 2009.

Remidio

Medical Equipment ManufacturingKarnataka, India201-500 Employees

Today, the human eye is unlocking early insights into systemic health, and Remidio is at the forefront of this transformation. Remidio is a pioneer in AI-driven eye care, leading the shift from care of the eye to healthcare through the eye. As the first company to receive CDSCO approval in India for our adaptive ophthalmic AI, in addition to CE marking in Europe under Class II EU-MDR, we are redefining how diseases like diabetic retinopathy, glaucoma, and AMD are detected early, in close to patient contexts, while remaining confident of extending this to systemic disease detection such as CVD, CKD and liver diseases, in the future. 

With CE-marked, FDA 510(k)-registered devices, our solutions have screened 16 million+ patients across 40+ countries, integrating teleophthalmology and AI for fast, accurate diagnoses. Our innovative retinal imaging solutions ensure precision and efficiency in clinical workflows.

Our journey began humbly - thanks to the chance meeting of our founder, with a mission driven ophthalmologist, who brought into focus the need for decentralizing eye testing with simple to use and affordable devices.  That conversation, 15 years back, sparked a vision to make high-quality preventive care accessible to all. 

Guided by innovation, empathy, and a commitment to global impact, our journey is just beginning !

Section iconCompany Overview

Headquarters
Peenya Industrial Estate 1st Main Road No, 1-51-2/12, Vacuum Techniques Compound, 1st Cross Rd Bengaluru North, Karnataka 560058 IN
NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Founded
2009
Employees
201-500

Section iconFunding & Financials

  • $1M$10M

    Remidio's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    Remidio's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.